Associate Editor Jacques Devière, MD, PhD recommends this Original Article from the December issue “Detection and staging of esophageal cancers within Barrett’s esophagus is improved by assessment in specialized Barrett’s units.”
The authors clearly address a common problem in the assessment of patients having Barrett’s esophagus (BE) and dysplasia. In 2014, evaluation of these patients includes high-definition endoscopy, narrow-band imaging (NBI) or other electronic staining method, and Seattle protocol adherence. This is rarely available in endoscopy units that do not have both the volume for justifying time spent and material required for evaluation of these patients.
Although retrospective, this article illustrates the amplitude of the problem of suboptimal evaluation of patients having Barrett’s esophagus with dysplasia which may have an impact on management.
All patients with dysplastic BE should be referred for staging, endoscopic, and histopathological evaluations to specialized BE unit. The role of community practices in identifying these patients is paramount.
After optimal evaluation, decision about the definitive management course should be taken together with the referring physician.
Find the abstract for this article here.
The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.